Cargando…
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
Autores principales: | Wallwork, Rachel, Connolly, Caoilfhionn M, Shneyderman, Matthew, McMahan, Zsuzsanna, Mecoli, Christopher A, Wigley, Fredrick, Hummers, Laura K, Shah, Ami A, Paik, Julie J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045742/ https://www.ncbi.nlm.nih.gov/pubmed/35502180 http://dx.doi.org/10.1016/S2665-9913(22)00100-X |
Ejemplares similares
-
Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021) -
Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022) -
Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis
por: Dein, Eric J., et al.
Publicado: (2021) -
Biomarkers of pulmonary hypertension in patients with scleroderma: a case–control study
por: McMahan, Zsuzsanna, et al.
Publicado: (2015) -
Treatment of Kimura disease with mycophenolate mofetil monotherapy
por: Shah, Kalee, et al.
Publicado: (2017)